- Home
- ELVN vs IGIC Comparison
ELVN vs IGIC Comparison
Compare ELVN & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | IGIC |
|---|---|---|
| Founded | 2016 | 2001 |
| Country | United States | Jordan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | IGIC |
|---|---|---|
| Price | $16.84 | $25.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $41.20 | $30.33 |
| AVG Volume (30 Days) | ★ 767.6K | 46.8K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.81 |
| Revenue | N/A | ★ $525,808,999.00 |
| Revenue This Year | N/A | $6.05 |
| Revenue Next Year | N/A | $7.01 |
| P/E Ratio | ★ N/A | $9.03 |
| Revenue Growth | N/A | ★ 3.88 |
| 52 Week Low | $13.30 | $20.82 |
| 52 Week High | $25.37 | $27.76 |
Technical Indicators
Market Signals| Indicator | ELVN | IGIC |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 72.83 |
| Support Level | $15.71 | $24.86 |
| Resistance Level | $17.58 | $25.55 |
| Average True Range (ATR) | 1.36 | 0.36 |
| MACD | -0.43 | 0.09 |
| Stochastic Oscillator | 17.77 | 83.05 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About IGIC International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.